Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001735276-19-000016
Filing Date
2019-01-11
Accepted
2019-01-11 16:07:36
Documents
1
Period of Report
2019-01-10

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 3734
  Complete submission text file 0001735276-19-000016.txt   5147
Mailing Address 300 THIRD STREET CAMBRIDGE MA 02142
Business Address 300 THIRD STREET CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Issuer) CIK: 0001178670 (see all company filings)

EIN.: 770602661 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O HENRY SCHEIN INC 135 DORYER ROAD MELVILLE NY 11747
Business Address
HAMBURG MARGARET A (Reporting) CIK: 0001266917 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36407 | Film No.: 19522426